Neurol. praxi. 2019;20(4):302-306 | DOI: 10.36290/neu.2019.132

Farmacotherapy of headache, mainly migraine

MUDr. Irena Novotná
1. neurologická klinika LF MU, FN u sv. Anny, Centrum pro diagnostiku a léčbu bolestí hlavy, Brno

Headache is one of the most common disorders encountered by nearly everyone. It is primarily divided into primary, where the most typical variety is migraine and its forms, and secondary, where headache is a symptom of another illness and it accompanies this illness. After the illness is cured, headache most often disappears. Headaches are distinguished in detail according to International Headache Society classification. In a daily practice of a physician or farmacist, the most important classification is to primary and secondary headache. According to anamnesis, after excluding possible secondary reasons and with normal results of common support analyses we can say for sure that it is a primary headache. Not until then we can responsibly decide how to treat the headache. Therapeutic approaches when curing primary or secondary headaches can be totally different. The treatment should be effective and precisely aimed, not random, because the delay caused by low effect (and loss of confidence of the doctor by the patients) lengthens the suffering, which has a negative impact on the psychics of a person and also direct and indirect socio-economic consequences. For treatment we select (according to the cause) medicaments to stop acute aching, and possibly also a prophylactic treatment, following rehabilitation or psychical support.

Keywords: primary headache, secondary headache, classification, treatment, profylaxis

Published: September 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Novotná I. Farmacotherapy of headache, mainly migraine. Neurol. praxi. 2019;20(4):302-306. doi: 10.36290/neu.2019.132.
Download citation

References

  1. Headache Classification Commitee of the International Headache Society (IHS), The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38(1): 1-211. Go to original source...
  2. Kotas R, a kol. Migréna, patofyziologie a léčba. Praha, Maxdorf, 2001.
  3. Kotas R. Bolesti hlavy v klinické praxi. Praha, Maxdorf, 2015.
  4. Marková J. Bolesti hlavy při nadužívání akutní analgetické medikace. Neurol. praxi 2012; 13(1): 14-46.
  5. Nežádal T. Chronická migréna. Neurol. praxi 2019; 20(2): 115-120. Go to original source...
  6. Niedermayerová I. Bolesti hlavy u seniorů. Neurol. prax 2011; 12(2): 121-124.
  7. Parikh SK, Siberstein SD. Current status of antiepileptic drugs as ppreventive migraine therapy. Curr Treat Options Neurol 2001; 21: 16. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.